Rangachari Narasimhan

Title: Rangachari Narasimhan: Innovator in Cardiac Treatment

Introduction

Rangachari Narasimhan is a prominent inventor based in Saratoga, CA (US). He has made significant contributions to the field of cardiac treatment, holding a total of 8 patents. His innovative approaches focus on improving methods for treating heart conditions, particularly through novel pharmaceutical compositions.

Latest Patents

Among his latest patents, one notable invention is related to unit aerosol doses for anticoagulation. This patent discloses methods for the prophylactic treatment of acute coronary syndrome (ACS) by administering an effective amount of a pharmaceutical composition via inhalation. The composition includes at least one anticoagulant or antiplatelet agent that first enters the heart through the left atrium. Another significant patent involves a method to slow ventricular rate, which outlines formulations and kits for treating or preventing cardiac arrhythmia. This includes the use of selective β1 adrenergic receptor blockers, administered through inhalation or intranasal spray.

Career Highlights

Rangachari Narasimhan has worked with notable organizations such as Incarda Therapeutics, Inc. and the University of California. His work in these institutions has allowed him to develop and refine his innovative ideas in cardiac treatment.

Collaborations

Throughout his career, Narasimhan has collaborated with esteemed colleagues, including Carlos A. Schuler and Luiz Belardinelli. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Rangachari Narasimhan's contributions to cardiac treatment through his innovative patents highlight his dedication to improving patient care. His work continues to influence the field and offers promising solutions for heart conditions.